PainReform(PRFX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PRFX PainReform

Trading 11-21 13:26:23 EST

3.30

-0.86

-20.79%

High3.90	Low3.00	Vol363.81K
Open3.31	D1 Closing4.16	Amplitude21.63%
Mkt Cap7.34M	Tradable Cap7.28M	Total Shares2.23M
T/O1.25M	T/O Rate16.48%	Tradable Shares2.21M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"PRFX","market":"US","secType":"STK","nameCN":"PainReform","latestPrice":3.295,"timestamp":1732213573731,"preClose":4.16,"halted":0,"volume":363812,"delay":0,"floatShares":2207900,"shares":2226452,"eps":-30.573956,"marketStatus":"Trading","change":-0.865,"latestTime":"11-21 13:26:23 EST","open":3.3129,"high":3.9,"low":3.0001,"amount":1252544.0321584,"amplitude":0.216322,"askPrice":3.38,"askSize":100,"bidPrice":3.15,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-30.573956,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1732222800000},"marketStatusCode":2,"adr":0,"listingDate":1598932800000,"exchange":"NASDAQ","adjPreClose":4.16,"preHourTrading":{"tag":"盘前","latestPrice":3.7499,"preClose":4.16,"latestTime":"09:26 EST","volume":1962,"amount":6989.384655000001,"timestamp":1732199193203},"postHourTrading":{"tag":"盘后","latestPrice":0.96,"preClose":1.04,"latestTime":"19:49 EST","volume":177711,"amount":176495.13135,"timestamp":1732150189388},"volumeRatio":0.059519},"requestUrl":"/m/hq/s/PRFX/wiki","defaultTab":"wiki","newsList":[{"id":"2485410181","title":"PainReform (PRFX) Receives a Hold from Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2485410181","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485410181?lang=en_us&edition=fundamental","pubTime":"2024-11-22 01:15","pubTimestamp":1732209333,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Naz Rahman maintained a Hold rating on PainReform (PRFX – Research Report) yesterday. The company’s shares opened today at $3.3...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/painreform-prfx-receives-a-hold-from-maxim-group?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/painreform-prfx-receives-a-hold-from-maxim-group?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRFX","BK4007"],"gpt_icon":0},{"id":"2485109717","title":"PainReform Ltd trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2485109717","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485109717?lang=en_us&edition=fundamental","pubTime":"2024-11-21 08:50","pubTimestamp":1732150207,"startTime":"0","endTime":"0","summary":"19:50 EST PainReform (PRFX) Ltd trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/painreform-ltd-trading-halted-news-pending-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/painreform-ltd-trading-halted-news-pending-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PRFX"],"gpt_icon":0},{"id":"2485140494","title":"Nasdaq Tumbles Over 100 Points; TJX Earnings Top Views","url":"https://stock-news.laohu8.com/highlight/detail?id=2485140494","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485140494?lang=en_us&edition=fundamental","pubTime":"2024-11-21 01:28","pubTimestamp":1732123691,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/24/11/42095162/nasdaq-tumbles-over-100-points-tjx-earnings-top-views","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":[".IXIC","PCOM","TJX","XTKG","WSM","SOAR","NDAQ","FBRX","PRFX","QSI"],"gpt_icon":1},{"id":"2484146070","title":"PainReform's Shares Tumble After Data Issue Muddles Late-Stage Study of Non-Opioid Pain Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2484146070","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484146070?lang=en_us&edition=fundamental","pubTime":"2024-11-20 23:56","pubTimestamp":1732118180,"startTime":"0","endTime":"0","summary":"PainReform's  shares tumbled nearly 27% Wednesday after the specialty pharmaceuticals company blamed an \"incoherence of data\" for unclear results in the latter portion of a phase 3 trial evaluating its PRF-110 drug candidate as a non-opioid alternative treatment for post-surgical pain.Topline data from the late-stage study obtained by Lotus Clinical Research, a contract research organization hired by PainReform, indicates the company's extended-release formulation of a widely used local anesthetic showed statistically significant superiority in reducing pain during the first 48 hours following bunionectomy procedures, compared with patients treated with a placebo, the company said.But data from the subsequent 24-hour period, essential for evaluating the primary endpoint of the trial, was unclear. PainReform said it is working with Lotus to complete the analysis of that portion of the data, adding, \"At present, there can be no assurance that the effort to resolve the incoherence will be","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SSI","BK4007","PRFX"],"gpt_icon":1},{"id":"2484106831","title":"PainReform drops on late-stage trial data for post-surgical pain management after bunionectomy","url":"https://stock-news.laohu8.com/highlight/detail?id=2484106831","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484106831?lang=en_us&edition=fundamental","pubTime":"2024-11-20 22:38","pubTimestamp":1732113535,"startTime":"0","endTime":"0","summary":"PainReform  falls about 27% after partial topline data from its contract research organization, Lotus Clinical Research, for the Phase 3 trial evaluating PRF-110 in post-surgical pain management of patients undergoing bunionectomy. Initial analysis of the topline data indicates that PRF-110 demonstrated statistically significant superiority over placebo in reducing pain during the first 48 hours following surgery.  However, data pertaining to the subsequent 24-hour period, which is essential for assessing the primary endpoint of the trial, is currently unclear due to incoherence of the data. PainReform is collaborating with Lotus to resolve this to complete the analysis of this portion of the data. Source: Press Release","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4311920-painreform-drops-on-late-stage-trial-data-for-post-surgical-pain-management-after-bunionectomy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["PRFX","BK4007"],"gpt_icon":1},{"id":"2484547111","title":"PainReform announces data for PRF-110 Phase 3 trial, notes incoherence of data","url":"https://stock-news.laohu8.com/highlight/detail?id=2484547111","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484547111?lang=en_us&edition=fundamental","pubTime":"2024-11-20 21:41","pubTimestamp":1732110077,"startTime":"0","endTime":"0","summary":"PainReform (PRFX) announced the receipt of partial topline data from its contract research organization, CRO, Lotus Clinical Research, for the Phas...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/painreform-announces-data-for-prf-110-phase-3-trial-notes-incoherence-of-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/painreform-announces-data-for-prf-110-phase-3-trial-notes-incoherence-of-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRFX","PRF","BK4588","BK4585","BK4007"],"gpt_icon":0},{"id":"2484162731","title":"BRIEF-PainReform Announces Initial Topline Data For PRF-110 Phase 3 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2484162731","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484162731?lang=en_us&edition=fundamental","pubTime":"2024-11-20 21:34","pubTimestamp":1732109644,"startTime":"0","endTime":"0","summary":"BRIEF-PainReform Announces Initial Topline Data For PRF-110 Phase 3 Clinical TrialNov 20 (Reuters) - PainReform Ltd PRFX.O:PAINREFORM ANNOUNCES INITIAL TOPLINE DATA FOR PRF-110 PHASE 3 CLINICAL TRIALP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nTUABJGPTD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRFX"],"gpt_icon":1},{"id":"2484164891","title":"PainReform Announces Initial Topline Data for Prf-110 Phase 3 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2484164891","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484164891?lang=en_us&edition=fundamental","pubTime":"2024-11-20 21:30","pubTimestamp":1732109400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nTUABJGPTD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PRFX"],"gpt_icon":0},{"id":"2484116470","title":"PainReform Ltd - Collaborating With Lotus to Resolve Data Incoherence","url":"https://stock-news.laohu8.com/highlight/detail?id=2484116470","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484116470?lang=en_us&edition=fundamental","pubTime":"2024-11-20 21:30","pubTimestamp":1732109400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nTUABJGPTD:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRFX","BK4007"],"gpt_icon":0},{"id":"2484116407","title":"PainReform Ltd - Prf-110 Shows Statistically Significant Pain Reduction in First 48 Hours","url":"https://stock-news.laohu8.com/highlight/detail?id=2484116407","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484116407?lang=en_us&edition=fundamental","pubTime":"2024-11-20 21:30","pubTimestamp":1732109400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nTUABJGPTD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRFX","BK4007"],"gpt_icon":0},{"id":"2484450920","title":"Nasdaq Gains 100 Points; Lowe's Earnings Beat Views","url":"https://stock-news.laohu8.com/highlight/detail?id=2484450920","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484450920?lang=en_us&edition=fundamental","pubTime":"2024-11-20 01:09","pubTimestamp":1732036178,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/42069005/nasdaq-gains-100-points-lowes-earnings-beat-views","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NWTN","LOW","PRFX","NDAQ","PCOM","SMCI","CDRO",".IXIC","TRNR","INCY"],"gpt_icon":1},{"id":"2484980748","title":"PainReform Announces 1-for-4 Reverse Share Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2484980748","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484980748?lang=en_us&edition=fundamental","pubTime":"2024-11-19 06:26","pubTimestamp":1731968778,"startTime":"0","endTime":"0","summary":"PainReform (PRFX) has released an update. PainReform Ltd. will implement a 1-for-4 reverse share split of its ordinary shares, effective after mark...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/painreform-announces-1-for-4-reverse-share-split?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/painreform-announces-1-for-4-reverse-share-split?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PRFX"],"gpt_icon":0},{"id":"2482573950","title":"PainReform Ltd  expected to post a loss of $4.74 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2482573950","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482573950?lang=en_us&edition=fundamental","pubTime":"2024-11-11 23:34","pubTimestamp":1731339258,"startTime":"0","endTime":"0","summary":"PainReform Ltd  expected to post a loss of $4.74 a share - Earnings Preview PainReform Ltd PRFX.OQ PRFX.O is expected to report resultson November 13 (estimated) for the period ending September 30 202","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241111:nL8N3MI16P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRFX"],"gpt_icon":0},{"id":"2481655931","title":"BRIEF-Painreform Announces Receipt Of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2481655931","media":"Reuters","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481655931?lang=en_us&edition=fundamental","pubTime":"2024-11-08 07:19","pubTimestamp":1731021580,"startTime":"0","endTime":"0","summary":"Nov 7 (Reuters) - Nasdaq Inc   :   * PAINREFORM ANNOUNCES RECEIPT OF NASDAQ NOTICE REGARDING MINIMUM STOCKHOLDERS’ EQUITY REQUIREMENTSource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EQR","IE00B64PRP62.GBP","SQQQ","NDAQ","LU2210149790.SGD","PRFX","IE00B3QW5Z07.USD","LU2210150020.SGD","TQQQ","NQmain","IE00BKPKM429.USD","BK4588","BK4112","LU2095319765.USD","BK4585","QID","BK4215","IE00BGHQF748.EUR",".IXIC","QLD","MNQmain","PSQ","BK4007"],"gpt_icon":0},{"id":"2481818168","title":"PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2481818168","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481818168?lang=en_us&edition=fundamental","pubTime":"2024-11-08 06:00","pubTimestamp":1731016800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nTUA8WXGNW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NDAQ","IE00B64PRP62.GBP","IE00BKPKM429.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4588","BK4585","BK4007","BK4112","LU2095319765.USD","LU2210149790.SGD","PRFX","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2481603181","title":"PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2481603181","media":"GlobeNewswire","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481603181?lang=en_us&edition=fundamental","pubTime":"2024-11-08 06:00","pubTimestamp":1731016800,"startTime":"0","endTime":"0","summary":"This notification has no immediate effect on the listing or trading of PainReform’s ordinary shares on the Nasdaq Capital Market TEL AVIV, Israel, Nov.  07, 2024  (GLOBE NEWSWIRE) -- PainReform Ltd. (","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/07/2977282/0/en/PainReform-Announces-Receipt-of-Nasdaq-Notice-Regarding-Minimum-Stockholders-Equity-Requirement.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRFX","IE00BKPKM429.USD","IE00B3QW5Z07.USD","TQQQ","BK4585","BK4112","MNQmain","LU2210149790.SGD","BK4215",".IXIC","BK4007","IE00B64PRP62.GBP","NDAQ","QLD","LU2095319765.USD","PSQ","QID","NQmain","EQR","LU2210150020.SGD","IE00BGHQF748.EUR","BK4588","SQQQ"],"gpt_icon":1},{"id":"2477656296","title":"Maxim Downgrades PainReform to Hold From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2477656296","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477656296?lang=en_us&edition=fundamental","pubTime":"2024-10-24 23:15","pubTimestamp":1729782959,"startTime":"0","endTime":"0","summary":"Price: 0.71, Change: -0.03, Percent Change: -3.44","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRFX"],"gpt_icon":0},{"id":"2477984631","title":"PainReform Cut to Hold From Buy by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2477984631","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477984631?lang=en_us&edition=fundamental","pubTime":"2024-10-24 21:43","pubTimestamp":1729777380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRFX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 24, 2024 09:43 ET (13:43 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRFX"],"gpt_icon":0},{"id":"2477063133","title":"PainReform cut to Hold at Maxim amid ‘changed’ market dynamics","url":"https://stock-news.laohu8.com/highlight/detail?id=2477063133","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477063133?lang=en_us&edition=fundamental","pubTime":"2024-10-24 21:25","pubTimestamp":1729776316,"startTime":"0","endTime":"0","summary":"As previously reported, Maxim analyst Naz Rahman downgraded PainReform (PRFX) to Hold from Buy. The company is developing PRF-110 to treat post-ope...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/painreform-cut-to-hold-at-maxim-amid-changed-market-dynamics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/painreform-cut-to-hold-at-maxim-amid-changed-market-dynamics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PRFX"],"gpt_icon":0},{"id":"2477682303","title":"PainReform downgraded to Hold from Buy at Maxim","url":"https://stock-news.laohu8.com/highlight/detail?id=2477682303","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477682303?lang=en_us&edition=fundamental","pubTime":"2024-10-24 19:55","pubTimestamp":1729770907,"startTime":"0","endTime":"0","summary":"Maxim analyst Naz Rahman downgraded PainReform (PRFX) to Hold from Buy. Published first on TheFly – the ultimate source for real-time, market-movin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/painreform-downgraded-to-hold-from-buy-at-maxim?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/painreform-downgraded-to-hold-from-buy-at-maxim?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRFX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.painreform.com","stockEarnings":[{"period":"1week","weight":0.7839},{"period":"1month","weight":0.4052},{"period":"3month","weight":-0.3528},{"period":"6month","weight":-0.7524},{"period":"1year","weight":-0.9159},{"period":"ytd","weight":-0.937}],"compareEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":0.0118},{"period":"3month","weight":0.0616},{"period":"6month","weight":0.1153},{"period":"1year","weight":0.3028},{"period":"ytd","weight":0.2423}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. The company engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. It is currently conducting Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. The company was incorporated in 2007 and is based in Tel Aviv, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.055707},{"month":2,"riseRate":0.5,"avgChangeRate":0.138423},{"month":3,"riseRate":0.5,"avgChangeRate":-0.007289},{"month":4,"riseRate":0,"avgChangeRate":-0.300309},{"month":5,"riseRate":0,"avgChangeRate":-0.127434},{"month":6,"riseRate":0.5,"avgChangeRate":-0.034279},{"month":7,"riseRate":0.5,"avgChangeRate":-0.026582},{"month":8,"riseRate":0.25,"avgChangeRate":-0.202384},{"month":9,"riseRate":0.25,"avgChangeRate":-0.207842},{"month":10,"riseRate":0,"avgChangeRate":-0.170305},{"month":11,"riseRate":0.6,"avgChangeRate":0.157434},{"month":12,"riseRate":0.25,"avgChangeRate":-0.07605}],"exchange":"NASDAQ","name":"PainReform","nameEN":"PainReform"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PainReform(PRFX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest PainReform(PRFX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"PainReform,PRFX,PainReform股票,PainReform股票老虎,PainReform股票老虎国际,PainReform行情,PainReform股票行情,PainReform股价,PainReform股市,PainReform股票价格,PainReform股票交易,PainReform股票购买,PainReform股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PainReform(PRFX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest PainReform(PRFX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}